DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Current Clinical Trials


Xeloda Related Clinical Trials

LBH589 in Combination With Capecitabine Plus/Minus (�) Lapatinib in Breast Cancer Patients [Completed]

A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors [Completed]

Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer [Active, not recruiting]

Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Completed]

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Completed]

Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer [Active, not recruiting]

Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC [Recruiting]

Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer [Completed]

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Completed]

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer [Completed]

Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer [Completed]

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma [Terminated]

Study of Capecitabine In Patients With Solid Tumors [Completed]

Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism [Not yet recruiting]

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer [Recruiting]

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer [Active, not recruiting]

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors [Completed]

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab [Active, not recruiting]

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study [Completed]

Xeloda (Capecitabine) and External Beam Radiation [Active, not recruiting]

QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer [Active, not recruiting]

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight [Recruiting]

Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater [Completed]

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [Completed]

Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors [Completed]

Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma [Active, not recruiting]

Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer [Recruiting]

Study of Capecitabine to Treat Recurrent High Grade Gliomas [Completed]

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis [Recruiting]

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older [Terminated]

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma [Recruiting]

Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) [Completed]

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer [Terminated]

Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Completed]

Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer [Completed]

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Terminated]

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma [Completed]

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC [Completed]

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer [Completed]

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma [Completed]

A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer [Completed]

Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab [Recruiting]

Ph II Study Examining Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation &/or Chemotherapy [Completed]

TaxXel: Taxotere and Xeloda in Esophageal Cancer [Active, not recruiting]

XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach [Recruiting]

Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer [Recruiting]

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer [Not yet recruiting]

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Active, not recruiting]

Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer [Recruiting]

Standard Versus Continuous Capecitabine in Advanced Breast Cancer [Active, not recruiting]

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer [Completed]

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma [Recruiting]

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV [Recruiting]

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Completed]

Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater [Active, not recruiting]

Phase II Study of Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer [Recruiting]

A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together [Completed]

Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Active, not recruiting]

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Terminated]

A Phase 1b Study of ONT-380 Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer [Recruiting]

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib [Completed]

Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer [Recruiting]

Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma [Terminated]

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. [Active, not recruiting]

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Terminated]

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer [Recruiting]

Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Completed]

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors [Completed]

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer [Active, not recruiting]

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer [Completed]

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma [Terminated]

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer [Completed]

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer [Not yet recruiting]

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer [Terminated]

Concurrent Xeloda and Radiotherapy for Bone Metastases [Recruiting]

Curcumin With Pre-operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer [Active, not recruiting]

A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor [Completed]

Capecitabine + BKM120 TNBC BC Brain Met [Recruiting]

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer [Completed]

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer [Terminated]

Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer [Completed]

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma [Completed]

Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma [Completed]

Azacitidine and CAPOX in Metastatic Colorectal Cancer [Active, not recruiting]

A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas [Completed]

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer [Completed]

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer [Recruiting]

Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [Completed]

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model [Completed]

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer [Recruiting]

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Active, not recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017